Chandigarh Herald

DelveInsight Business Research LLP

DelveInsight’s “Agoraphobia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Agoraphobia, historical and forecasted epidemiology as well as the Agoraphobia market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Agoraphobia Overview

Agoraphobia is a mental and behavioral disorder, specifically an anxiety disorder characterized by symptoms of anxiety in situations where the person perceives their environment to be unsafe with no easy way to escape.

Agoraphobia is believed to be due to a combination of genetic and environmental factors.The condition often runs in families, and stressful or traumatic events such as the death of a parent or being attacked may be a trigger.

Agoraphobia Epidemiology Insights

• The National Institute of Mental Health estimates that the lifetime prevalence of agoraphobia is 1.3%, with an annual incidence rate of 0.9%. Yearly prevalence rates of agoraphobia are similar between males (0.8%) and females (0.9%).

Click here to learn more about the Agoraphobia Market Landscape

The Report Covers the Agoraphobia Epidemiology Segmented by:

• Agoraphobia incident cases 

• Agoraphobia prevalent cases 

• Agoraphobia diagnosed cases 

• Agoraphobia treatment cases 

Agoraphobia Market Outlook 

The Agoraphobia market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Agoraphobia market trends by analyzing the impact of current Agoraphobia therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Agoraphobia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Agoraphobia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Agoraphobia market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Agoraphobia Market

• Johnson and Johnson 

• AstraZeneca 

• Bristol Myers Squibb

• Sandoz Inc 

• Mylan Pharmaceuticals 

And many others 

Agoraphobia Therapies Covered and Analyzed in the Report:

•  Fluoxetine 

•  Citalopram

• Escitalopram 

And many others 

Learn more about the Key Companies and Emerging Therapies in the Agoraphobia Market

Table of Contents 

1. Key Insights 

2. Agoraphobia Introduction 

3. Executive Summary of Agoraphobia  

4. Disease Background and Overview

5. Epidemiology and patient population

6. Agoraphobia Emerging Therapies

7. Agoraphobia Market Outlook

8. Market Access and Reimbursement of Therapies

9. Market Drivers 

10. Market Barriers 

11. Appendix

12. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

Learn about the detailed offerings of the report @ Agoraphobia Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services